InsightRX, a precision medicine company founded in 2015, offers to optimize drug dosage for the individual patient. Efforts in precision medicine, currently, focuses only on selecting the right drug for the right patient and drug dosage is overlooked. According to the company, its InsightRX software platform provides an informed patient-specific dose by leveraging machine learning, mathematical models, patient demographics, physiological characteristics, pharmacogenomic data, drug concentrations. The company operates in the Healthcare IT sector with additional focus on Genomics and Clinical Genomics. Its business model centers on Dosage. Founded in 2015, headquartered in San Francisco, United States. The company has raised $13.3M at the Series A stage. Backed by investors including Canadian Imperial Bank of Commerce, GreatPoint Ventures, OSF HealthCare, HealthX Ventures, Rock Health and others.
InsightRx
Series AInsightRX, a precision medicine company founded in 2015, offers to optimize drug dosage for the individual patient. Efforts in precision medicine, currently, focuses only on selecting the right drug for the right patient and drug dosage is overlooked. According to the company, its InsightRX software platform provides an informed patient-specific dose by leveraging machine learning, mathematical models, patient…
About
Business model
Healthcare IT > Provider > Clinical Operations > Decision Support > Therapy Plan > Medication > Dosage,
Genomics > Applied Genomics > Clinical Genomics > Diagnostics > Sequencing-based > Precision Medicine,
Plug and Play Tech Center Batches > Health > Batch 0,
MassChallenge Batches > HealthTech > 2018
Institutional investors
Latest coverage
📰 See all funding news — keep up with the raises that set comps.
Investor directory
🗂️ See who's investing in HealthTech — full fund directory with check size and geography.